Propionic Acid

Propionic Acid

SCHEMBL4174066

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)N3CCCC3)cc2c2cc[nH]c12

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
GAA P10253 2/20 0.48
ATM Q13315 1/20 0.48
TP53 P04637 1/20 0.47
HTT P42858 3/20 0.45
HSD17B10 Q99714 5/20 0.45
ALDH1A1 P00352 2/20 0.45
ALPL P05186 1/20 0.45
BACE1 P56817 1/20 0.45
MAPT P10636 3/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 1/20 0.44
CYP2C9 P11712 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4174097 0.92 HSD17B10 (0.55) KDM4EGAAHTTHSD17B10ALDH1A1
Propionic Acid SCHEMBL4157681 0.91 GAA (0.54) KDM4EGAAHSD17B10ALDH1A1MAPT
Propionic Acid SCHEMBL4162761 0.87 KDM4E (0.42) KDM4EGAATP53HTTHSD17B10
Propionic Acid SCHEMBL4155193 0.87 RXFP1 (0.41) KDM4EHTTHSD17B10ALDH1A1MAPT
Propionic Acid SCHEMBL4173362 0.84 KDM4E (0.45) KDM4EHTTHSD17B10BACE1KMT2A
Propionic Acid SCHEMBL4166334 0.84 KDM4E (0.45) KDM4EHTTHSD17B10BACE1KMT2A
Propionic Acid SCHEMBL4162918 0.84 BRAF (0.46) KDM4EMAPT
Butyric Acid SCHEMBL4160300 0.82 MEN1 (0.45) KDM4EGAATP53HTTKMT2A
Propionic Acid SCHEMBL4160991 0.82 BRD4 (0.39) KDM4ETP53HTTHSD17B10ALDH1A1
Propionic Acid SCHEMBL4154867 0.82 TSHR (0.51) GAAHTTALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 KDM4E 1970/4885GAA 3035/4885ATM 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.